These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 628007)

  • 21. Synthesis and some pharmacological properties of [1-beta-mercapto-beta,beta-diethylpropionic acid,2-(3,5-dibromo-L-tyrosine)]oxytocin.
    Lundell EO; Smith CW; Ferger MF
    J Med Chem; 1975 Dec; 18(12):1262-4. PubMed ID: 1195281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and some pharmacological properties of [4-threonine,7-sarcosine]oxytocin, a peptide with high oxytocic potency, and of [4-threonine,7-N-methylalanine]oxytocin.
    Grzonka Z; Lammek B; Gazis D; Schwartz IL
    J Med Chem; 1983 Dec; 26(12):1786-7. PubMed ID: 6685771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and pharmacological properties of [1-L-penicillamine,4-L-leucine]oxytocin.
    Ferger MF; Chan WY
    J Med Chem; 1975 Oct; 18(10):1020-2. PubMed ID: 1159679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and biological activity of oxytocin analogues containing conformationally-restricted residues in position 7.
    Fragiadaki M; Magafa V; Borovicková L; Slaninová J; Cordopatis P
    Eur J Med Chem; 2007 Jun; 42(6):799-806. PubMed ID: 17316912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The biological activity of a new analogue of oxytocin in which the tyrosyl group is replaced by phenylalanyl.
    KONZETT H; BERDE B
    Br J Pharmacol Chemother; 1959 Mar; 14(1):133-6. PubMed ID: 13651590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxytocin analogs with substitutions in postions 3 and 4.
    Roy J; Havran RT; Schwartz IL; Walter R
    Int J Pept Protein Res; 1975; 7(2):171-8. PubMed ID: 1140889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and pharmacological evaluation of an analogue of the peptide hormone oxytocin that contains a mimetic of an inverse gamma-turn.
    Yuan Z; Blomberg D; Sethson I; Brickmann K; Ekholm K; Johansson B; Nilsson A; Kihlberg J
    J Med Chem; 2002 Jun; 45(12):2512-9. PubMed ID: 12036359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthetic metabolites of neurohypophyseal hormones. (Des-9-glycinamide)oxytocin and (des-9-glycinamide, des-8-leucine)oxytocin.
    Walter R; Havran RT; Schwartz IL
    J Med Chem; 1976 Feb; 19(2):328-30. PubMed ID: 1249815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The synthesis and some pharmacological properties of (2-L-DOPA)-oxytocin.
    Ferrier BM; Branda LA
    Can J Biochem; 1976 May; 54(5):507-11. PubMed ID: 1276975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study of pituitary hormone analogs for their inhibitory properties and resistance to carboxamidopeptidases: (9-L-proline)oxytocin, (9-L-glutamic acid)oxytocin, and (8-L-lysine,9-glycine methylamide)oxytocin.
    Grzonka Z; Glass JD; Schwartz IL; Walter R
    J Med Chem; 1974 Dec; 17(12):1294-8. PubMed ID: 4427327
    [No Abstract]   [Full Text] [Related]  

  • 31. Systematic substitution of an oxytocin antagonist with D-amino acids: unexpected high antagonistic potency of the D-Cys6-substituted analogue.
    Flouret G; Majewski T; Brieher W; Wilson L
    J Med Chem; 1993 Mar; 36(6):747-9. PubMed ID: 8459401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and some pharmacological properties of five analogs of oxytocin having L-homocysteine in position 6.
    Smith CW; Ferger MF
    J Med Chem; 1976 Feb; 19(2):250-4. PubMed ID: 1249804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a novel class of cyclic hexapeptide oxytocin antagonists based on a natural product.
    Williams PD; Bock MG; Tung RD; Garsky VM; Perlow DS; Erb JM; Lundell GF; Gould NP; Whitter WL; Hoffman JB
    J Med Chem; 1992 Oct; 35(21):3905-18. PubMed ID: 1331448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [1-Deaminopenicillamine,4-threonine]oxytocin, a potent inhibitor of oxytocin.
    Manning M; Lowbridge J; Seto J; Haldar J; Sawyer WH
    J Med Chem; 1978 Feb; 21(2):179-82. PubMed ID: 621712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-activity studies of a novel bicyclic oxytocin antagonist.
    Smith DD; Slaninova J; Hruby VJ
    J Med Chem; 1992 May; 35(9):1558-63. PubMed ID: 1578481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and some pharmacological properties of oxytocin analogues having L-thiazolidine-4-carboxylic acid in position 7.
    Rosamond JD; Ferger MF
    J Med Chem; 1976 Jul; 19(7):873-6. PubMed ID: 940106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conformationally biased analogs of oxytocin.
    Lebl M; Toth G; Slaninová J; Hruby VJ
    Int J Pept Protein Res; 1992 Aug; 40(2):148-51. PubMed ID: 1446971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. (1-beta-mercapto-beta,beta-diethylpropionic acid,4-leucine)-8-lysine-vasopressin and (1-beta-mercapto-beta,beta-diethylpropionic acid,4-leucine)oxytocin, compounds possessing antihormonal properties.
    Dyckes DF; Nestor JJ; Ferger MF; Du Vigneaud V; Chan WY
    J Med Chem; 1974 Sep; 17(9):969-72. PubMed ID: 4855467
    [No Abstract]   [Full Text] [Related]  

  • 39. Proposed conformation of oxytocin in solution.
    Urry DW; Walter R
    Proc Natl Acad Sci U S A; 1971 May; 68(5):956-8. PubMed ID: 5280529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design of novel bicyclic analogues derived from a potent oxytocin antagonist.
    Flouret G; Chaloin O; Borovickova L; Slaninová J
    J Pept Sci; 2006 Jun; 12(6):412-9. PubMed ID: 16432806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.